Multicentric, Prospective, Randomized, Comparing Trial Between Bypass of the Femoropoplitea by PTFE and Heparin Bounded PTFE

Multicentric, Prospective, Randomized, Comparing Trial Between Bypass of the Femoropoplitea by PTFE and Heparin Bounded PTFE

Comparison of two kinds of protheses for bridging of the femoropoplitea and/or femorotibiale: PTFE with or without bounded heparin

Comparison of two kinds of protheses for bridging of the femoropoplitea and/or femorotibiale: PTFE with or without bounded heparin.

Evaluation of this comparison by clinical systems: ankle-arm index, duplex echo, follow-up of 2 years

Inclusion Criteria:

• Patients with Peripheral Vascular Diseases with complaints of invalidating claudication, rest pain, ucera or gangrene
• Patients with damage of the arteria femoralis superficialis or poplitea, longer than 6 cm
• Reasonable outflow arteria
• Informed consent
• Patient able to take part in all follow-up examinations

Exclusion Criteria:

• Acute ischemia of the leg
• Patients with a ipsilateral inflow stenosis of more than 70% which can not be corrected before or during the surgery
• < 18 years
• Pregnancy
• Recent heart attack (< 1 month)
• Life expectancy less than 12 months
• Known allergy to heparin
• Known contrast allergy
• Known bleeding or coagulation disorder